How Von Hippel-Lindau Is Diagnosed

Table of Contents
View All
Table of Contents

Von Hippel-Lindau (VHL) disease is a rare genetic condition in which tumors, both non-cancerous (benign) and cancerous, form in certain areas of the body due to a mutation in the VHL gene. The VHL gene is a tumor suppressor gene. When it doesn’t work properly, tumor cells can grow out of control.

This article will review how VHL is diagnosed through a physical exam, laboratory testing, and imaging. 

A lab professional conducting a genetic blood test

seksan Mongkhonkhamsao / Getty Images

Self-Checks/At-Home Testing 

There aren’t currently any at-home testing kits to diagnose VHL. It is most often diagnosed after someone is discovered to have the tumors likely associated with VHL.

An evaluation that can be completed at home is a thorough and accurate family history. Although about 20% of VHL happens spontaneously, 80% of VHL is passed down in a family. A child born to a parent with VHL has a 50% chance of inheriting the VHL mutation. A healthcare provider should be notified if there is a family history of VHL.  

Physical Examination 

If VHL is suspected or being evaluated, a physical exam by a healthcare provider can be an important step in diagnosis. VHL most often causes benign tumors called hemangioblastomas. Although they aren’t cancerous, they may cause other problems or side effects. Some of these that a healthcare provider may be looking for during an exam may include:

  • High blood pressure
  • Vision changes
  • Sweating
  • Abdominal bloating
  • Hearing loss
  • Abdominal or pelvic pain
  • Balance problems
  • Weakness of the arms or legs
  • Blood in the urine

Labs and Tests 

VHL is ultimately diagnosed through genetic testing. This is not done to screen the general population, but is used when a diagnosis of VHL is suspected. The following are some findings that may suggest the presence of VHL:

  • Multiple hemangioblastomas in the retina (the light-sensing layer in the back of the eye), brain, or spinal cord
  • One hemangioblastoma plus the presence of clear cell renal cancer, cysts in the pancreas, pheochromocytoma (a hormone-producing tumor of the adrenal glands), or epididymal cyst (a fluid-filled pocket on the tube that carries and stores sperm)
  • Having clear cell renal cell carcinoma in both kidneys

This genetic testing may also be done when someone has a family history of VHL, and may be done as early as infancy for a child born to a parent with VHL.

Molecular genetic testing is used to look for the presence of a mutation in the VHL gene. Single gene tests may be used, or a larger molecular panel may be ordered, which also looks for mutations in other genes. These are done through blood testing. Results may take a few weeks to return.

Imaging

Although the diagnosis of VHL is made through genetic testing, there are findings on imaging tests that may cause healthcare providers to be suspicious of a diagnosis of VHL. Imaging may include either computerized tomography (CT) or magnetic resonance imaging (MRI) of multiple areas to look for the following:

  • Hemangioblastomas in the brain, spinal cord, or eyes
  • Pheochromocytomas (lesions on the adrenal glands)
  • Cysts or tumors on the pancreas
  • Cysts or tumors in the kidneys
  • Tumors in the reproductive organs of all sexes
  • Tumors in the inner ear

Differential Diagnoses 

People who have a single hemangioblastoma, renal cell carcinoma, or pheochromocytoma may not necessarily have VHL. These are conditions that can occur without a mutation in the VHL gene.

There are other genetic conditions that can cause multiple tumors to form. You may be evaluated for these if VHL is suspected. These other genetic conditions include:

  • Multiple endocrine neoplasia type 2 (a condition in which tumors form on endocrine glands, often on the parathyroid gland, pituitary gland, and pancreas)
  • Hereditary paraganglioma-pheochromocytoma syndrome (an inherited disease with tumor growth near nerve bundles)
  • Neurofibromatosis 1 (a genetic condition where benign tumors grow under the skin, near the spinal cord, and in the brain)
  • Meniere’s disease (an inner ear disorder that can cause dizziness and ringing in the ears)

Summary 

The diagnosis of VHL is ultimately made through genetic testing, which finds the mutation in the VHL gene. This testing may be prompted by the finding of suspicious tumors or cysts on imaging studies. The imaging studies are done to evaluate the symptoms these tumors may cause.

Although many of the findings on physical exam or imaging may be caused by conditions other than VHL, it is certainly a consideration when someone has a family history of VHL, if they have retinal hemangioblastomas or multiple findings on imaging that suggest VHL. 

A Word From Verywell

Knowing your family history can be important for many reasons, but especially important if you have a family history of VHL.

If you have VHL, keeping up with your appointments with healthcare providers for imaging and screenings is important. These can find any tumors or cysts early and keep you as healthy as possible. Talk to your healthcare team about any new symptoms that develop or any questions that you have about VHL.

8 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Lin G, Zhao Y, Zhang Z, Zhang H. Clinical diagnosis, treatment and screening of the VHL gene in three von Hippel‑Lindau disease pedigreesExperimental and Therapeutic Medicine. 2020;20(2):1237-1244. doi:10.3892/etm.2020.8829

  2. National Organization of Rare Disorders. Von Hippel-Lindau disease.

  3. American Society of Clinical Oncology. Von Hippel-Lindau syndrome.

  4. van Leeuwaarde RS, Ahmad S, Links TP, Giles RH. Von Hippel-Lindau syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. University of Washington, Seattle; 1993.

  5. MedlinePlus. Multiple endocrine neoplasia.

  6. MedlinePlus. Hereditary paraganglioma-pheochromocytoma.

  7. MedlinePlus. Neurofibromatosis type 1.

  8. MedlinePlus. Meniere's disease.

By Julie Scott, MSN, ANP-BC, AOCNP
Julie is an Adult Nurse Practitioner with oncology certification and a healthcare freelance writer with an interest in educating patients and the healthcare community.